7 Top Israeli Healthcare Startups You Should Know

In-person session | Engage

September 15, 2022 | 6:15 pm - 7:00 pm
Room: Cafe Space
ABOUT THE SESSION

In 2021, Israel’s digital health startups raised $1.9B in funding (Startup Nation Central). What are the innovations that are infusing this investment surge and who are some of the most promising startups?

Join us to meet with 7 top Israeli digital health startups you should know.

Each of them has raised between $1.5M and $6M in Venture Capital in Israel. They’ve spent the past 7 weeks working with the Science Center to strategize potential partnerships and investments in to the US market, with an emphasis on Philadelphia.

Register now to RSVP on Thursday, September 15th (and get a sneak peek below).

Scaling with Partners
Explore Groundbreaking Healthcare Innovation in Israel
Partnerships are critical to any growth strategy, though this is particularly true in Israel. With more startups and unicorns – private companies valued at $1 billion or more – per sq capita than any other country, Israel's high-tech sector continues to skyrocket. Through the right partnerships and commercialization support, the US healthcare market stands to benefit.

Over the second half of 2022, we'll explore the critical role of the Israeli and Philadelphia partnership, how it is accelerating digital health innovation, and what this means for you.
University City Science Center | IN-VENTech
Investor Program 2022
Atvisor
Aging people and people with disabilities can significantly improve their life by using Assistive Technology (AT). Yet only 10% will benefit from using it due to lack of awareness, funding, leadership, and coaching. Atvisor has developed an AI-based digital health platform that supports assistive technology assessments and the decision-making process. Our AI engine steers users to the optimal product - products they often were unaware that existedaccording to their personal abilities, limitations and needs. Our mission is to improve the lives of
millions by making Assistive Technologies more accessible and personalized.
Droxi
IPrimary care physicians spend 2.5-3 hours a day performing exhausting non-patient facing tasks: Patient requests, prior authorizations, prescription refills, and lab results reviews. As a result of the pandemic, this burden keeps increasing, and primary care physicians are busier than ever before, suffering from massive physician burnout. Solution: Droxi's AI tool helps primary care physicians reduce the amount of time spent on non-patient-facing tasks and improve the quality of care by creating a Patient-Specific Storytelling. Physicians no longer have to go through dozens of different tabs and thousands of fields in the medical record. Instead, Droxi identifies and visualizes the most relevant clinical factors for each task so that physicians can cross them off their list quickly.
Innosphere
Innosphere provides a non-invasive electrical brain-stimulation medical device, AI based for treating ADHD without side effects. Our AI algorithm allows to personalize the treatment by tailoring the treatment protocol according to the symptom's severity of each child. Innosphere has achieved excellent results from the clinical trial that we conducted at Hadassah Medical Center in Jerusalem, where we managed to reduce the ADHD symptoms severity by nearly 50% after ten treatment sessions of 20 minutes each, with a long-lasting effect over two months. This clinical trial was led by Prof. Itai Berger from Assuta Medical Center and Prof. Roi Cohen Kadosh from Oxford University in collaboration with Prof. Bruce Wexler from Yale University. The results were published in the prestigious Neurophysiology Journal.
Kai.ai
Kai.ai is a VC-backed venture on a mission to democratize mental health for teens. Our hybrid AI conversational coaching platform helps teens build habits for healthy living and resilience, integrating seamlessly with all the top messaging apps (Apple Messages, WhatsApp, Discord, Telegram, etc.) Founded by repeat entrepreneurs, including two clinical psychologists, Kai has raised $2.8M to date, led by Rainfall Ventures.
NyX
NyX is a VC-backed, science-based neuro-tech company that is changing the sleep paradigm. The company is currently developing a sleek, attractive headband that uses sophisticated algorithms and continuous-learning artificial intelligence to personalize a program that trains people's brains for sleep. Based on active and adaptive technology, we offer safe and effective solutions that immediately enhance the natural quality of sleep.
Paragate Medical
Paragate Medical is addressing one of the greatest unmet needs in healthcare: a solution for chronic fluid-overload heart and kidney failure patients, who are considered the “frequent flyers” of the hospitals. The company develops the IPUD, a fully implantable device that actively prevents fluid accumulation and the resulting need for frequent admissions by continuously and slowly draining systemic excess fluids from the tissues to the urinary system, as a mechanical bypass of the kidneys. This solution is first of its kind to provide a truly out-of-hospital 24/7 treatment.
Profility
Combining EMR summary techniques, sophisticated AI and big data access, Profility helps set the right treatment for the right cost, in the best matched facility. The platform oversees the patient from admission through hospitalization to post-acute care, and the solutions support all the critical decision points in the continuum of care. Profility is a cloudbased platform with multiple solutions, serving all the relevant decision makers – acute teams, post-acute provider teams and the payers. Profility is fully operational, working with leading providers in the US, serving thousands of patients every month.

IN-VENTech is a unique startup program backed by Haifa Municipality, hiCenter and Haifa Economic Corporation. The program was initiated to support and promote the growing innovation ecosystem in downtown Haifa. The Science Center IN-VENTech cohort engages Israeli healthcare startups in a 7-week training program focused on investor discovery and developing partnerships in Philadelphia and U.S.-based R&D organizations. These companies have satisfied proof-of-concept and established traction in Israel, either through customers and revenue or investment. The companies have raised between $1.5M and $6M in venture capital in Israel, and seek expansion into the U.S. market. Online training topics include an overview of the U.S. healthcare market, engaging in investor discovery, U.S. regulatory issues, and panel sessions with U.S. investors. The program concludes with a one-week visit to Philadelphia consisting of a blend of training topics, partner meetings, and an Israeli Innovation Night on September 15 at the Science Center.

MORE SESSIONS
September 15, 2022
Venture Café Philadelphia is powered by Science Center.